Journal of Gastrointestinal Cancer

Long-Term Association Between GLP-1 Receptor Agonist Use and Incident Pancreatic Cancer: A Propensity Score-Matched Retrospective Cohort Study Using the TriNetX Network

By Muhammad Ali Ibrahim Kazi, Junaid Khan, Syed Musa Mufarrih, Andrew Canakis

Figure 1 from Journal of Gastrointestinal Cancer — Figure 1. Kazi et al.

Cohort study in peopleInterventions

Declared no competing interests

The paper

Muhammad Ali Ibrahim Kazi, Junaid Khan, Syed Musa Mufarrih, Andrew Canakis

Anne Arundel Medical Center; Peninsula Regional Medical Center

Journal of Gastrointestinal Cancer, 16 Sep 2026

doi.org/10.1007/s12029-026-01523-w PubMed 42745130

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes, Obesity & Metabolism4 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression